AwesomeCapital
Search This Blog
Thursday, January 23, 2020
Epizyme target upped to $35 from $25 by Citigroup
Maintains Buy
https://www.benzinga.com/stock/EPZM/rating
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.